Rosalind Advisors’s EyePoint Inc EYPT Stock Holding History

Rosalind Advisors’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Buy	+50,300	New	+$673K	0.05%	32

Other funds holding EYPT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Rosalind Advisors's EYPT Position: Q2 2026 in Review

Rosalind Advisors reduced its EyePoint Inc (EYPT) stake by 4.7% in Q2 2026, selling an estimated $649K and leaving 988,230 shares worth $14.1M. The position accounts for 5.25% of the portfolio, ranked #7.

Rosalind Advisors first reported a position in EYPT in Q3 2025 and has held it in 4 quarters since. 189 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

Rosalind Advisors held 988,230 shares of EyePoint Inc worth $14.1M as of Q2 2026.
Rosalind Advisors sold 48,507 EyePoint Inc shares in Q2 2026, an estimated $649K.
EyePoint Inc made up 5.25% of Rosalind Advisors's portfolio in Q2 2026, its #7 holding.
Rosalind Advisors first reported a position in EyePoint Inc in Q3 2025 and has held it in 4 quarters since.
189 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.